Tibet Cheezheng Tibetan Medicine Co Ltd Class A 002287
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 20.33
- Day Range
- CNY 20.17–20.45
- 52-Week Range
- CNY 16.27–26.48
- Bid/Ask
- CNY 20.27 / CNY 20.29
- Market Cap
- CNY 10.75 Bil
- Volume/Avg
- 661,392 / 1.3 Mil
Key Statistics
- Price/Earnings (Normalized)
- 27.16
- Price/Sales
- 5.08
- Dividend Yield (Trailing)
- 1.92%
- Dividend Yield (Forward)
- 1.92%
- Total Yield
- 1.92%
Company Profile
Tibet Cheezheng Tibetan Medicine Co Ltd is Tibetan medicine manufacturer. It is mainly engaged in the research, development, production, and sales of Tibetan medicines. The company's products include medicines such as emplastrum, ointments, granules, pills, and powders.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 3,091
- Website
- http://www.cheezheng.com.cn
Comparables
Valuation
|
Metric
|
002287
|
002873
|
688658
|
|---|---|---|---|
Price/Earnings (Normalized) | 27.16 | 33.28 | 62.95 |
Price/Book Value | 2.81 | 2.03 | 2.23 |
Price/Sales | 5.08 | 2.37 | 2.03 |
Price/Cash Flow | 15.72 | 22.18 | 11.44 |
Price/Earnings
002287
002873
688658
Financial Strength
|
Metric
|
002287
|
002873
|
688658
|
|---|---|---|---|
Quick Ratio | 2.14 | 0.65 | 1.37 |
Current Ratio | 2.28 | 0.97 | 1.78 |
Interest Coverage | 11.23 | 8.01 | 12.43 |
Quick Ratio
002287
002873
688658
Profitability
|
Metric
|
002287
|
002873
|
688658
|
|---|---|---|---|
Return on Assets (Normalized) | 6.17% | 3.36% | −1.44% |
Return on Equity (Normalized) | 11.00% | 5.84% | −2.32% |
Return on Invested Capital (Normalized) | 7.97% | 4.27% | −2.20% |
Return on Assets
002287
002873
688658
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk A/S ADR
NVO
| Ymkltnbks | Fnx | $635.4 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Jzqmvcn | Xkghhpn | $124.1 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Vhwtjxqt | Yrzdgmt | $114.2 Bil | |||
| Moderna Inc
MRNA
| Pfxmnnn | Pwyms | $53.7 Bil | |||
| argenx SE ADR
ARGX
| Qgxywksgw | Qrxb | $23.0 Bil | |||
| BioNTech SE ADR
BNTX
| Kbncjrnr | Rfl | $22.2 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Spnkkwnq | Kzpvvdq | $20.3 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Txdrqlpzc | Ywkhfg | $15.9 Bil | |||
| United Therapeutics Corp
UTHR
| Mxbgrpsgg | Tzcb | $12.8 Bil | |||
| Incyte Corp
INCY
| Sxntrqnn | Pfnsyw | $12.2 Bil |